We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$419M
AUM Growth
+$56.7M
Cap. Flow
+$128M
Cap. Flow %
30.67%
Top 10 Hldgs %
66.93%
Holding
92
New
53
Increased
2
Reduced
10
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 3.56%
3 Industrials 3.21%
4 Consumer Discretionary 2.78%
5 Real Estate 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTI icon
1
Vanguard Total Stock Market ETF
VTI
$654B
$165M 39.44%
750,000
-15,000
-2% -$3.13M
QQQ icon
2
Invesco QQQ Trust
QQQ
$444B
$31.4M 7.5%
85,000
+28,000
+49% +$9.43M
GPCR icon
3
Structure Therapeutics
GPCR
$3.38B
$22.8M 5.43%
1,370,991
+1,200,991
+706% +$33.7M
RDNT icon
4
RadNet
RDNT
$4.89B
$9.79M 2.34%
+300,000
New +$8.72M
NXT icon
5
Nextpower Inc
NXT
$14.9B
$7.97M 1.9%
+200,154
New +$7.34M
CWST icon
6
Casella Waste Systems
CWST
$5.78B
$7.69M 1.84%
+85,000
New +$7.58M
GEHC icon
7
GE HealthCare
GEHC
$28.4B
$7.31M 1.75%
+90,000
New +$7.18M
CMPX icon
8
Compass Therapeutics
CMPX
$371M
$6.26M 1.49%
1,969,296
-207,746
-10% -$652K
AXSM icon
9
Axsome Therapeutics
AXSM
$12.3B
$5.39M 1.29%
+75,000
New +$5.53M
MKSI icon
10
MKS Inc
MKSI
$19.4B
$4.32M 1.03%
+40,000
New +$3.66M
GTLS
11
DELISTED
Chart Industries
GTLS
$4.31M 1.03%
27,000
-9,468
-26% -$1.21M
ROIV icon
12
Roivant Sciences
ROIV
$24.7B
$4.03M 0.96%
400,000
-100,000
-20% -$894K
ARGX icon
13
argenx
ARGX
$55.8B
$3.9M 0.93%
10,000
MBLY icon
14
Mobileye
MBLY
$2.03B
$3.84M 0.92%
+100,000
New +$4.06M
LCID icon
15
Lucid Motors
LCID
$2.5B
$3.38M 0.81%
+49,000
New +$3.5M
VTMX icon
16
Vesta Real Estate
VTMX
$3.21B
$3.22M 0.77%
+100,000
New +$3.22M
RHP icon
17
Ryman Hospitality Properties
RHP
$8.52B
$3.02M 0.72%
+32,500
New +$2.99M
PLGO
18
Pelagos Insurance Capital
PLGO
$2.23B
$2.73M 0.65%
+200,000
New +$2.65M
MLTX icon
19
MoonLake Immunotherapeutics
MLTX
$1.67B
$2.55M 0.61%
+50,000
New +$1.35M
USPH icon
20
US Physical Therapy
USPH
$1.18B
$2.43M 0.58%
+20,000
New +$2.16M
DAWN
21
DELISTED
Day One Biopharmaceuticals
DAWN
$2.39M 0.57%
+199,900
New +$2.61M
MOND
22
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$2.18M 0.52%
+245,000
New +$2.49M
GPOR icon
23
Gulfport Energy Corp
GPOR
$2.8B
$2.1M 0.5%
+20,000
New +$1.85M
IRON icon
24
Disc Medicine
IRON
$2.85B
$2M 0.48%
+45,000
New +$1.6M
ZURA icon
25
Zura Bio
ZURA
$508M
$1.97M 0.47%
+240,000
New +$1.93M

Similar funds

Monashee Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, Monashee Investment Management held 92 positions worth $419M, up 16% from $362M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Monashee Investment Management deployed $128M of net new capital in Q2 2023, opening 53 new positions and adding to 2 existing holdings. Its largest new stake was RadNet: 300,000 shares worth $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Alight, an estimated $6.95M trimmed.

  • Monashee Investment Management's largest Q2 2023 buy was RadNet: 300,000 shares worth $9.79M.
  • Monashee Investment Management added most to Structure Therapeutics in Q2 2023, an estimated $33.7M increase.
  • Monashee Investment Management's biggest Q2 2023 reduction was Alight, cutting an estimated $6.95M.
  • Monashee Investment Management fully exited iShares Russell 2000 ETF in Q2 2023, selling an estimated $16.9M.
  • Monashee Investment Management's ten largest holdings make up 67% of its $419M portfolio in Q2 2023.
  • Monashee Investment Management opened 53 new positions and closed 24 in Q2 2023.
  • Monashee Investment Management's portfolio value rose 16% quarter-over-quarter to $419M.

Based on Monashee Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.